Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.
2.

Glucose intolerance with atypical antipsychotics.

Hedenmalm K, Hägg S, Ståhl M, Mortimer O, Spigset O.

Drug Saf. 2002;25(15):1107-16.

PMID:
12452735
3.

Venous thromboembolism in recipients of antipsychotics: incidence, mechanisms and management.

Jönsson AK, Spigset O, Hägg S.

CNS Drugs. 2012 Aug 1;26(8):649-62. doi: 10.2165/11633920-000000000-00000. Review.

PMID:
22731933
4.

Atypical antipsychotic drugs and diabetes mellitus in the US Food and Drug Administration Adverse Event database: a systematic Bayesian signal detection analysis.

Baker RA, Pikalov A, Tran QV, Kremenets T, Arani RB, Doraiswamy PM.

Psychopharmacol Bull. 2009;42(1):11-31.

PMID:
19204649
5.

Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).

DuMouchel W, Fram D, Yang X, Mahmoud RA, Grogg AL, Engelhart L, Ramaswamy K.

Ann Clin Psychiatry. 2008 Jan-Mar;20(1):21-31. doi: 10.1080/10401230701844612.

PMID:
18297583
6.

Risk of venous thromboembolism during treatment with antipsychotic agents.

Masopust J, Malý R, Vališ M.

Psychiatry Clin Neurosci. 2012 Dec;66(7):541-52. doi: 10.1111/pcn.12001. Review.

7.

Thrombotic complications of treatment with antipsychotic drugs.

Shulman M, Jennifer Njoku I, Manu P.

Minerva Med. 2013 Apr;104(2):175-84. Review.

PMID:
23514994
8.

Stability of medication in early psychosis: a comparison between second-generation and low-dose first-generation antipsychotics.

Opjordsmoen S, Melle I, Friis S, Haahr U, Johannessen JO, Larsen TK, Rund BR, Simonsen E, Vaglum P, McGlashan TH.

Early Interv Psychiatry. 2009 Feb;3(1):58-65. doi: 10.1111/j.1751-7893.2008.00103.x.

PMID:
21352176
9.

Antipsychotic drug use and the risk of venous thromboembolism in elderly patients with dementia.

Schmedt N, Garbe E.

J Clin Psychopharmacol. 2013 Dec;33(6):753-8. doi: 10.1097/JCP.0b013e3182a412d5.

PMID:
24052055
10.

Seizure risk associated with neuroactive drugs: data from the WHO adverse drug reactions database.

Kumlien E, Lundberg PO.

Seizure. 2010 Mar;19(2):69-73. doi: 10.1016/j.seizure.2009.11.005. Epub 2009 Dec 24.

11.

Antipsychotics and venous thromboembolism risk: a meta-analysis.

Zhang R, Dong L, Shao F, Tan X, Ying K.

Pharmacopsychiatry. 2011 Jul;44(5):183-8. doi: 10.1055/s-0031-1280814. Epub 2011 Jul 7.

PMID:
21739416
12.

Antipsychotic drugs and risk of idiopathic venous thromboembolism: a nested case-control study using the CPRD.

Ishiguro C, Wang X, Li L, Jick S.

Pharmacoepidemiol Drug Saf. 2014 Nov;23(11):1168-75. doi: 10.1002/pds.3699. Epub 2014 Sep 7.

PMID:
25195779
13.

Paediatric atypical antipsychotic monitoring safety (PAMS) study: pilot study in children and adolescents in secondary- and tertiary-care settings.

Rani FA, Byrne PJ, Murray ML, Carter P, Wong IC.

Drug Saf. 2009;32(4):325-33. doi: 10.2165/00002018-200932040-00006.

PMID:
19388723
14.

Evaluating the association between clozapine and venous thromboembolism.

Paciullo CA.

Am J Health Syst Pharm. 2008 Oct 1;65(19):1825-9. doi: 10.2146/ajhp070638. Review.

PMID:
18796423
15.

Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study.

Coulter DM, Bate A, Meyboom RH, Lindquist M, Edwards IR.

BMJ. 2001 May 19;322(7296):1207-9.

16.

Antipsychotic drugs and venous thromboembolism.

Tromeur C, Couturaud F.

Thromb Res. 2012 Oct;130 Suppl 1:S29-31. doi: 10.1016/j.thromres.2012.08.267. Review.

PMID:
23026655
17.

Four cases of venous thromboembolism associated with olanzapine.

Maly R, Masopust J, Hosak L, Urban A.

Psychiatry Clin Neurosci. 2009 Feb;63(1):116-8. doi: 10.1111/j.1440-1819.2008.01899.x. Epub 2008 Dec 1.

18.

Hyponatraemia as an adverse drug reaction of antipsychotic drugs: a case-control study in VigiBase.

Mannesse CK, van Puijenbroek EP, Jansen PA, van Marum RJ, Souverein PC, Egberts TC.

Drug Saf. 2010 Jul 1;33(7):569-78. doi: 10.2165/11532560-000000000-00000.

PMID:
20553058
19.

[Specific treatments of the psychiatric community and thrombogenesis].

Khammassi N, Chrifi J, Hamza M, Cherif O.

Encephale. 2013 Apr;39(2):143-8. doi: 10.1016/j.encep.2012.06.007. Epub 2012 Aug 24. Review. French.

PMID:
23095579
20.

Hyperglycemia associated with antipsychotic treatment in a multicenter drug safety project.

Kropp S, Grohmann R, Hauser U, Rüther E, Degner D.

Pharmacopsychiatry. 2004 Mar;37 Suppl 1:S79-83.

PMID:
15052518

Supplemental Content

Support Center